DAICHI MORITA

Last Updated :2024/06/04

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Pharmaceutical Sciences), Assistant Professor
E-mail
dmoritahiroshima-u.ac.jp
Self-introduction
To control the infectious diseases by multidrug resistant bacteria, I'm trying to clarify the whole picture of drug resistance mechanism. I also try to develop novel antimicrobial agents.

Basic Information

Major Professional Backgrounds

  • 2016/04, 2016/06, Okayama University, Researcher
  • 2016/07/01, 2018/03/31, Okayama University, Assistant Professor (Special Appointment)
  • 2018/04/01, 2019/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Assistant Professor

Educational Backgrounds

  • Okayama University, Japan, 2012/04, 2016/03
  • Okayama University, Japan, 2006/04, 2012/03

Academic Degrees

  • Okayama University

Educational Activity

  • [Bachelor Degree Program] School of Pharmaceutical Sciences : Program of Pharmaceutical Sciences : Pharmaceutical Sciences
  • [Bachelor Degree Program] School of Pharmaceutical Sciences : Program of Medicinal Sciences : Medicinal Sciences
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medicinal Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medicinal Sciences

Research Fields

  • Medicine,dentistry, and pharmacy;Pharmacy;Biological pharmacy

Research Keywords

  • Microbiology, Antimicrobial resistance

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, 4Term, Microbiology
  2. 2024, Undergraduate Education, First Semester, Practice of Microbiology
  3. 2024, Undergraduate Education, 2Term, Antibiotics and Drug resistance
  4. 2024, Undergraduate Education, First Semester, Experiments of Microbial Chemistry
  5. 2024, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences I
  6. 2024, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences II
  7. 2024, Undergraduate Education, Second Semester, Special laboratory Works in Pharmaceutical Sciences III
  8. 2024, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy I
  9. 2024, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy II
  10. 2024, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy III
  11. 2024, Graduate Education (Master's Program) , First Semester, Seminar on Microbiology
  12. 2024, Graduate Education (Master's Program) , Second Semester, Seminar on Microbiology
  13. 2024, Graduate Education (Master's Program) , First Semester, Research on Microbiology
  14. 2024, Graduate Education (Master's Program) , Second Semester, Research on Microbiology
  15. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Microbiology
  16. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Microbiology
  17. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Microbiology
  18. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Microbiology

Research Activities

Academic Papers

  1. Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India, Journal of Antimicrobial Chemotherapy, dkae024, 20240209
  2. ★, Whole-Genome and Plasmid Comparative Analysis of Campylobacter jejuni from Human Patients in Toyama, Japan, from 2015 to 2019, Microbiology Spectrum, 11(1), 20230109
  3. Complete Genome Sequence of Herbiconiux sp. Strain L3-i23 Isolated from Soil in Japan, MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 11(11), 20221117
  4. Diversity and characteristics of pTet family plasmids revealed by genomic epidemiology of Campylobacter jejuni from human patients in Toyama, Japan from 2015 to 2019, bioRxiv, 20220628
  5. Draft Genome Sequence of Paenibacillus sp. Strain L3-i20, Isolated from Soil in Japan, Microbiol Resour Announc, 11(6), e0007722, 20220616
  6. Genome Sequence-Guided Finding of Lucensomycin Production by Streptomyces achromogenes Subsp. streptozoticus NBRC14001, MICROORGANISMS, 10(1), 20211226
  7. Virulence of Cholera Toxin Gene-Positive Vibrio cholerae Non-O1/non-O139 Strains Isolated From Environmental Water in Kolkata, India, Front Microbiol, 20(12), 726273, 20210820
  8. ★, Whole-Genome Analysis of Clinical Vibrio cholerae O1 in Kolkata, India, and Dhaka, Bangladesh, Reveals Two Lineages of Circulating Strains, Indicating Variation in Genomic Attributes, mBio, 11(6), 20201106
  9. Genome Mining-Based Discovery of Fungal Macrolides Modified by glycosylphosphatidylinositol (GPI)-Ethanolamine Phosphate Transferase Homologues, Organic letters, 22(15), 5876-5879, 20200807
  10. ★, Altered Integrative and Conjugative Elements (ICEs) in Recent Vibrio cholerae O1 Isolated From Cholera Cases, Kolkata, India., Front. Microbiol, 6(10), 2072, 20190906
  11. Comprehensive analysis of resistance-nodulation-cell division superfamily (RND) efflux pumps from Serratia marcescens, Db10, SCIENTIFIC REPORTS, 9, 4854, 20190319
  12. Minimum structural requirements for cell membrane leakage-mediated anti-MRSA activity of macrocyclic bis(bibenzyl)s., Bioorg Med Chem Lett., 26(9), 2324-2327, 20160301
  13. Anti-MRSA activity of isoplagiochin-type macrocyclic bis(bibenzyl)s is mediated through cell membrane damage., Bioorg Med Chem., 23(13), 3309-3316, 20150701
  14. Structure-anti-MRSA activity relationship of macrocyclic bis(bibenzyl) derivatives., Bioorg Med Chem Lett., 23(24), 6563-6568, 20131215
  15. Riccardin C derivatives as anti-MRSA agents: structure-activity relationship of a series of hydroxylated bis(bibenzyl)s., Bioorg Med Chem Lett., 22(24), 7444-7447, 20121215
  16. Genomic characterization of antibiotic resistance-encoding genes in clinical isolates of Vibrio cholerae non-O1/non-O139 strains from Kolkata, India: generation of novel types of genomic islands containing plural antibiotic resistance genes, MICROBIOLOGY AND IMMUNOLOGY, 64(6), 435-444, 202006
  17. ★, Riccardin C derivatives cause cell leakage in Staphylococcus aureus., Biochim Biophys Acta. (Biomembrane), 1848(10), 2057-2064, 201510

Invited Lecture, Oral Presentation, Poster Presentation

  1. Getting Started with Genome Analysis, Daichi Morita, OU-HU-KU-NICED Joint Seminar and Technical Training Workshop on Next Generation Sequencing and Data Analysis 2022, 2022/11/14, With Invitation, English, ICMR, Kolkata
  2. Genetic diversity of Enterotoxigenic Escherichia coli (ETEC) and Campylobacter in India and Japan, Daichi Morita, Junko Isobe, Emi Maenishi, Takanori Kumagai, Yuki Yamamoto, Miyuki Kanda, Hidetoshi Tahara, Kei Kitahara, Shin-ichi Miyoshi, Asish K Mukhopadhyay, Shanta Dutta, Fumito Maruyama, Teruo Kuroda, 16th Asian Conference of Diarrhoeal Disease and Nutrition, 2022/11/12, Without Invitation, English, ICMR, Kolkata
  3. Comparison of genetic diversity of Enterotoxigenic Escherichia coli (ETEC) and Campylobacter in India and Japan, Daichi Morita, Junko Isobe, Emi Maenishi, Takanori Kumagai, Yuki Yamamoto, Miyuki Kanda, Hidetoshi Tahara, Kei Kitahara, Shin-ichi Miyoshi, Asish K Mukhopadhyay, Shanta Dutta, Fumito Maruyama, Teruo Kuroda, 2022/11/12, Without Invitation, English, ICMR, Kolkata

External Funds

Acceptance Results of Competitive Funds

  1. 2020, 2022

Social Activities

History as Peer Reviews of Academic Papers

  1. 2020, Microbiology and Immunology, 1
  2. 2020, Research in Microbiology, 1
  3. 2021, Journal of Disaster Research, 1
  4. 2022, Frontiers in Public Health, 1
  5. 2022, Biocontrol Science, 1
  6. 2021, Biocontrol Science, 1
  7. 2020, Biocontrol Science, 1
  8. 2017, Microbiology and Immunology, 1
  9. 2017, Biocontrol Science, 1
  10. 2018, Biocontrol Science, 1
  11. 2019, Biocontrol Science, 1
  12. 2019, Microbiology and Immunology, 1